Citation: boethig d et al.Mid term course after pediatric right ventricular outflow tract reconstruction: a comparison of homografts, porcine xenografts and contegras.European journal of cardio-thoracic surgery.2005; (27) 58¿66.Doi:10.1016/j.Ejcts.2004.09.009.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding explants and reoperation rates between different devices used to reconstruct the right ventricular outflow tract (rvot).All data were collected from a single center between april 1991 and january 2003.The study population included 190 patients (predominantly female; mean age 4.3 years), 109 of which were implanted with a medtronic contegra conduit (serial numbers were not provided).Among all contegra patients, there was an observed hospital mortality rate of 7.4% (below the expected rate of 10.2%).None of the deaths were attributed to medtronic product.Among all patients observed adverse events included: pulmonary artery stenosis, ossification, calcification, and reoperations including explant of the conduit.No additional adverse patient effects or product performance issues were reported.
|